Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Erdheim-Chester Disease × 68Ga-pentixafor × 90 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Myeloid 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Sinus 1 Erdheim-Chester Disease 1

Interventions

trametinib 1 dabrafenib 1 68Ga-pentixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05093335 2026-02-05

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting

LymphoidMyeloidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Histiocytosis, Sinus, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡